BridgeMD
New treatment option for Hypnosis
Official title Pain Management With Virtual Reality Hypnosis
ClinicalTrials.gov ID: NCT06502457
What this study is testing
What is painkiller?
painkiller is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for hypnosis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The latency phase corresponds to the first phase of the first stage of labour, during which the parturient feels regular, rhythmic uterine contractions that are often painful, with or without changes of the cervix. This phase lasts an average of 8 hours for primiparous women, compared with 5 hours for multiparous women, and can last up to twenty hours in total.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Parturient over 18
- Parturient who speaks and understands French
- Parturient hospitalised prior to labour
- Membranes intact or ruptured
- Spontaneous or induced labour
You likely can't join if
- Parturient under legal protection
- Parturient with a hearing impairment
- Parturient with visual impairment
- Parturient with epilepsy
- Parturient with psychiatric problems
- Pathological pregnancy
See the full eligibility criteria
- Parturient over 18
- Parturient who speaks and understands French
- Parturient hospitalised prior to labour
- Membranes intact or ruptured
- Spontaneous or induced labour
- Parturient in latency phase
- Term ≥ 37SA
- END \> 3
- Parturient requiring active pain management (medicinal or non-medicinal)
- Low-risk pregnancy
- Parturient under legal protection
- Parturient with a hearing impairment
- Parturient with visual impairment
- Parturient with epilepsy
- Parturient with psychiatric problems
- Pathological pregnancy
- Parturient with chronic pain
- Parturient with addiction-related disorders
- Parturient allergic to paracetamol
- Parturient allergic to phloroglucinol
- Parturient allergic to codeine
- Parturient allergic to nalbuphine
- Parturient allergic to orozamudol
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.